RS51047B - Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola - Google Patents

Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola

Info

Publication number
RS51047B
RS51047B YUP-2005/0375A YUP20050375A RS51047B RS 51047 B RS51047 B RS 51047B YU P20050375 A YUP20050375 A YU P20050375A RS 51047 B RS51047 B RS 51047B
Authority
RS
Serbia
Prior art keywords
alkyl
integer
phenanthryl
anthryl
heteroaryl
Prior art date
Application number
YUP-2005/0375A
Other languages
English (en)
Inventor
Zhengming Chen
Original Assignee
Euroceltique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroceltique S.A. filed Critical Euroceltique S.A.
Publication of RS20050375A publication Critical patent/RS20050375A/sr
Publication of RS51047B publication Critical patent/RS51047B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

Jedinjenje forumle (Ia) ili (lb):ili njegova farmaceutski prihvatljiva so, gde:Ar je -C3-C8 cicloalkil, fenil, naftil, antril, fenantril, ili -(5- do 7-člani) heteroaril, od kojih je svaki supstituisan ili nesupstituisan sa jednom ili više R2 grupa;Ar2 je fenil, naftil, antril, fenantril, ili -(5- do 7-člani)heteroaril, od kojih je svaki supstituisan ili nesupstituisan sa jednom ili više R2 grupa;G je -H, -L- (CH2)nCO2R4, -L-(CH2)nR5, (C1-C5 alkilen) CO2R4, ili (C1-C5 alkilen)R5;L = -C(O)- , -SO2- ili -SO- ;R1= H, -C(O)NH2, -C(O)NHOH, -CO2R4, -CHO, -CN, -(C1-C4 alkil), -C(O)NH (C1-C4 alkil), -C(O)N(C1-C4 alkil)2,R2 i R3 su svaki nezavisno -halogen, -C1-C3 alkil, -O(C1-C3 alkil), -NH(C1-C3 alkil) ili -N(C1-C3alkil)2;R4 = -H, -C1-C10 alkil, -CH2O(C1-C4 alkil), -CH2N(C1-C4 alkil)2, ili -CH2NH(C1-C4 alkil);R5 = -NH2, -NHSO2R4, -C(O)NH2, -C(O)NHOH, -SO2NH2, -C (O) NH (C1-C4 alkil), -C(O)N(C1-C4 alkil)2, -SO2NH(C1-C4 alkil), -SO2N(C1-C4 alkil)2, -H, -OH, -CN, -C3-C8 cikloalkil, fenil, naftil, antril, fenantril, ili -(5-do 7-člani) heteroaril, od kojih je svaki supstituisan ili nesupstituisan sa jednom ili više R2 grupa;m = celi broj od 0 do 4;n = celi broj od 1 do 4;p = 0 ili 1;q = celi broj od 0 do 3; ir = celi broj od 1 do 6;Prijava sadrži još 27 patentnih zahteva.
YUP-2005/0375A 2002-11-18 2003-11-17 Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola RS51047B (sr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42738102P 2002-11-18 2002-11-18
US46027803P 2003-04-03 2003-04-03
US48848803P 2003-07-17 2003-07-17
US10/714,066 US7202259B2 (en) 2002-11-18 2003-11-13 Therapeutic agents useful for treating pain
PCT/US2003/036742 WO2004046132A1 (en) 2002-11-18 2003-11-17 4-tetrazolyl-4phenylpiperidine derivatives for treating pain

Publications (2)

Publication Number Publication Date
RS20050375A RS20050375A (en) 2007-11-15
RS51047B true RS51047B (sr) 2010-10-31

Family

ID=32777221

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0375A RS51047B (sr) 2002-11-18 2003-11-17 Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola

Country Status (37)

Country Link
US (3) US7202259B2 (sr)
EP (2) EP1562932B9 (sr)
JP (2) JP4601429B2 (sr)
KR (1) KR20050115221A (sr)
CN (2) CN100567288C (sr)
AP (1) AP2210A (sr)
AR (1) AR047008A1 (sr)
AT (2) ATE402167T1 (sr)
AU (2) AU2003294313B2 (sr)
BR (1) BR0316305A (sr)
CA (1) CA2506242C (sr)
CO (1) CO5690588A2 (sr)
CR (2) CR7877A (sr)
CY (2) CY1107682T1 (sr)
DE (2) DE60322451D1 (sr)
DK (2) DK1803718T3 (sr)
EA (1) EA008621B1 (sr)
EC (1) ECSP055840A (sr)
ES (2) ES2285235T3 (sr)
GE (1) GEP20084539B (sr)
HK (1) HK1086829A1 (sr)
IL (1) IL209352A0 (sr)
IS (2) IS2720B (sr)
MA (1) MA27565A1 (sr)
ME (1) MEP48108A (sr)
MX (1) MXPA05004669A (sr)
MY (1) MY135647A (sr)
NI (1) NI200500087A (sr)
NO (1) NO20052894L (sr)
NZ (2) NZ540068A (sr)
OA (1) OA13010A (sr)
PT (2) PT1803718E (sr)
RS (1) RS51047B (sr)
SG (1) SG165998A1 (sr)
SI (2) SI1562932T1 (sr)
TW (2) TWI343917B (sr)
WO (1) WO2004046132A1 (sr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
ME00276B (me) 2003-04-30 2011-05-10 Purdue Pharma Lp Transdermalni dozni oblik otporan na promjene koje sadrže komponentu aktivnog sredstva i komponentu suprotnog sredstva na mjestu koji je ispod sloja aktivnog sredstva
JP4634401B2 (ja) 2004-01-30 2011-02-16 ユーロ−セルティーク エス．エイ． ４−テトラゾリル−４−フェニルピペリジン化合物の製造方法
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
EP2298764A1 (en) * 2005-11-21 2011-03-23 Purdue Pharma LP 4-Oxadiazolyl-piperidine compounds and use thereof
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
MX2013003354A (es) 2010-09-21 2013-06-24 Purdue Pharma Lp Analogos de buprenorfina.
CN102648915B (zh) * 2011-02-28 2015-04-15 鲁南制药集团股份有限公司 一种治疗或预防神经病理性疼痛的药物组合物
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
CA2890655A1 (en) 2012-11-09 2014-05-15 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
TW201434842A (zh) 2012-12-07 2014-09-16 Purdue Pharma Lp 丁基原啡因（ｂｕｐｒｅｎｏｒｐｈｉｎｅ）類似物類
CA2894963A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
WO2014091297A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
JP6182620B2 (ja) 2013-01-31 2017-08-16 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015097546A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Propellane-based compounds and their use as opioid receptor modulators
EP3087073B1 (en) 2013-12-26 2018-07-04 Purdue Pharma LP 10-substituted morphinan hydantoins
EP3087078B1 (en) 2013-12-26 2019-05-15 Purdue Pharma LP 7-beta-alkyl analogs of orvinols
CA2934913A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Ring-contracted morphinans and the use thereof
EP3087079B1 (en) 2013-12-26 2019-04-03 Purdue Pharma LP Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
US10550088B2 (en) 2013-12-27 2020-02-04 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
WO2015183780A1 (en) 2014-05-27 2015-12-03 Purdue Pharma L.P. Spirocyclic morphinans and use thereof
CA2951697A1 (en) 2014-06-13 2015-12-17 Purdue Pharma L.P. Azamophinan derivatives and use thereof
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
WO2017165558A1 (en) 2016-03-22 2017-09-28 Regents Of The University Of Minnesota Combination for treating pain
US10745402B2 (en) 2017-01-02 2020-08-18 Purdue Pharma L.P. Morphinan derivatives and use thereof
BR112023023702A2 (pt) * 2021-05-21 2024-01-30 Purdue Pharma Lp Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga
WO2023250190A1 (en) * 2022-06-24 2023-12-28 Purdue Pharma L.P. Methods of treating or preventing overactive bladder syndrome

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE775611A (fr) 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DK162087D0 (da) * 1987-03-31 1987-03-31 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en) 1992-07-31 1995-09-12 Correa; Paulo N. Energy conversion system
US5606037A (en) 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
US5736523A (en) 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US6166085A (en) 1995-04-14 2000-12-26 The Regents Of The University Of California Method of producing analgesia
CA2224517A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
WO1997024325A1 (en) 1995-12-28 1997-07-10 Takeda Chemical Industries, Ltd. DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
BR9714787A (pt) * 1997-06-10 2000-07-18 Synthon Bv Compostos de 4- fenilpiperidina e processo para sua preparação
SK13092000A3 (sk) 1998-03-06 2001-03-12 Janssen Pharmaceutica N. V. Inhibítory prenosu glycínu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
US6358945B1 (en) 1999-03-12 2002-03-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
WO2001021169A1 (fr) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Antagonistes de l'hormone de concentration de la melanine
CA2324330A1 (en) 1999-11-08 2001-05-08 Ssp Co., Ltd. 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
ATE302770T1 (de) 1999-12-06 2005-09-15 Euro Celtique Sa Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
WO2001046206A1 (en) 1999-12-22 2001-06-28 Merck Frosst Canada & Co. Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US6703525B2 (en) 2000-02-16 2004-03-09 Boehringer Ingelheim Pharmaceuticals, Inc. Sulfonamide intermediates and methods of producing same
EP1277737A4 (en) 2000-03-24 2003-05-07 Meiji Seika Kaisha DIPHENYLALKYLAMINE DERIVATIVES AS AGONISTS OF THE OPIOID -g (d) RECEPTOR
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
AU2001294240A1 (en) 2000-10-12 2002-04-22 Ssp Co., Ltd. 2,2-diphenylbutanamide derivatives and medicines containing the same
AU2002226000A1 (en) 2000-11-13 2002-05-21 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
JP4634401B2 (ja) * 2004-01-30 2011-02-16 ユーロ−セルティーク エス．エイ． ４−テトラゾリル−４−フェニルピペリジン化合物の製造方法

Also Published As

Publication number Publication date
EP1562932B9 (en) 2007-09-12
AP2210A (en) 2011-02-25
MA27565A1 (fr) 2005-10-03
CO5690588A2 (es) 2006-10-31
ATE402167T1 (de) 2008-08-15
CY1107682T1 (el) 2013-04-18
CN1711256A (zh) 2005-12-21
NI200500087A (es) 2007-07-24
MXPA05004669A (es) 2005-06-08
MEP48108A (en) 2011-02-10
TW200418828A (en) 2004-10-01
NO20052894D0 (no) 2005-06-14
EP1562932A1 (en) 2005-08-17
NZ540068A (en) 2007-07-27
DE60313021T2 (de) 2007-12-13
IS2720B (is) 2011-02-15
AP2005003297A0 (en) 2005-06-30
CY1108422T1 (el) 2014-04-09
ECSP055840A (es) 2005-08-11
US20040152689A1 (en) 2004-08-05
AU2010246411A1 (en) 2010-12-16
RS20050375A (en) 2007-11-15
CN100567288C (zh) 2009-12-09
DK1803718T3 (da) 2008-10-27
NO20052894L (no) 2005-06-14
US20070179141A1 (en) 2007-08-02
CN101648941A (zh) 2010-02-17
IS8913A (is) 2010-07-21
CA2506242C (en) 2011-07-05
HK1086829A1 (en) 2006-09-29
US7687518B2 (en) 2010-03-30
AU2003294313B2 (en) 2010-08-26
AU2003294313A1 (en) 2004-06-15
US8026254B2 (en) 2011-09-27
EA008621B1 (ru) 2007-06-29
KR20050115221A (ko) 2005-12-07
JP4601429B2 (ja) 2010-12-22
US20100069437A1 (en) 2010-03-18
WO2004046132A1 (en) 2004-06-03
EP1803718A1 (en) 2007-07-04
TWI343917B (en) 2011-06-21
US7202259B2 (en) 2007-04-10
DK1562932T3 (da) 2007-08-13
PT1803718E (pt) 2008-09-26
TW200819436A (en) 2008-05-01
EP1803718B1 (en) 2008-07-23
DE60313021D1 (de) 2007-05-16
CA2506242A1 (en) 2004-06-03
EP1562932B1 (en) 2007-04-04
BR0316305A (pt) 2005-09-27
CR7877A (es) 2005-11-30
AR047008A1 (es) 2006-01-04
OA13010A (en) 2006-11-10
EA200500726A1 (ru) 2005-10-27
SI1562932T1 (sl) 2007-08-31
ES2312150T3 (es) 2009-02-16
JP2010163452A (ja) 2010-07-29
NZ572685A (en) 2010-06-25
IL209352A0 (en) 2011-01-31
PT1562932E (pt) 2007-07-02
SG165998A1 (en) 2010-11-29
ES2285235T3 (es) 2007-11-16
GEP20084539B (en) 2008-11-25
ATE358674T1 (de) 2007-04-15
CR11037A (es) 2009-10-29
DE60322451D1 (de) 2008-09-04
JP2006525944A (ja) 2006-11-16
SI1803718T1 (sl) 2008-12-31
MY135647A (en) 2008-06-30
IS7812A (is) 2005-04-19

Similar Documents

Publication Publication Date Title
RS51047B (sr) Derivati 4-tetrazolil-4-fenilpiperidina za lečenje bola
CO5251464A1 (es) Inhibidores de n-(5-(((5-alquil-2-oxazolil)metil)tio)-2- tiazolil)-carboxamida de cinasas dependientes de ciclina
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ME00411B (me) Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma
RS49921B (sr) Terapeutski biaril derivati
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
RS51471B (sr) Derivati bifeniloksisirćetne kiseline za tretman bolesti dišnog trakta
CO5080804A1 (es) Derivados biciclicos del acido hidroxamico
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
CO5251381A1 (es) Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen
PT1289955E (pt) Piperidinas para utilizacao como antagonistas dos receptores da orexina
EA200600509A1 (ru) Соединения пиримидотиофена
CO5601012A2 (es) Compuestos que modulan la actividad de ppar
AR035854A1 (es) Compuestos derivados de piridopirimidina y naftiridina, su uso, un procedimiento para prepararlos, una composicion que los comprende, compuestos intermediarios y un proceso para preparar un compuesto sulfuro
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
HRP20021023B1 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
MXPA06003250A (es) Oximas de benzofurano substituidas.
DE60142934D1 (de) Pharmazeutische dopamin-glykokonjugat-zusammensetzungen und verfahren zu deren herstellung
GB1046506A (en) Guanidine compounds and process for their manufacture
RS51193B (sr) Hidantoinski derivati korisni kao inhibitori metaloproteinaza
JP2006523698A5 (sr)
MEP22508A (en) Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
HRP20090147T3 (en) Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
EA200970364A1 (ru) Новые производные имидазолонов в качестве лекарственных средств, способ их получения, фармацевтические композиции и применение в качестве ингибиторов протеинкиназ, в частности, cdc7
YU47219B (sh) Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje